← Eichor
Study identifier: NCT03924791 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transforaminal Epidural Injection in Acute Sciatica

Condition: Sciatica · Sciatica Due to Intervertebral Disc Disorder · Sciatic Radiculopathy  ·  Sponsor: C.L.A.Vleggeert-Lankamp

PhaseNA
Planned participants142
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.

This description comes directly from the study's public registry record.

Talk to the study team

Carmen LA Vleggeert-Lankamp, MD Msc Ph.D  ·  +31715262109  ·  cvleggeert@lumc.nl

Eduard JA Verheijen, Bsc  ·  +31715262109  ·  e.j.a.verheijen@lumc.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Spaarne GasthuisHaarlem, NetherlandsRecruiting
Spaarne GasthuisHoofddorp, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03924791